Holen Sie sich die Stockscreener-App
9.54
2.81%
0.29
Handel nachbörslich:
9.54
Schlusskurs vom Vortag:
$9.25
Offen:
$9
24-Stunden-Volumen:
29,234
Relative Volume:
0.57
Marktkapitalisierung:
$5.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-17.06M
KGV:
-0.1349
EPS:
-70.7173
Netto-Cashflow:
$-14.18M
1W Leistung:
-4.90%
1M Leistung:
+28.69%
6M Leistung:
-38.09%
1J Leistung:
-87.22%
1-Tages-Spanne:
$8.599
$9.85
1-Wochen-Bereich:
$8.599
$10.59
52-Wochen-Spanne:
$4.93
$221.94
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Firmenname
Cns Pharmaceuticals Inc
Sektor
Branche
Telefon
1-800-946-9185
Adresse
2100 WEST LOOP SOUTH, HOUSTON
Vergleichen Sie CNSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
9.54 | 5.31M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | Eingeleitet | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Aktie (CNSP) Neueste Nachrichten
Will CNS Pharmaceuticals Inc. stock go up soon2025 Stock Rankings & Daily Momentum Trading Reports - newser.com
Is CNS Pharmaceuticals Inc. stock reversal real or fakeWeekly Investment Summary & Free High Return Stock Watch Alerts - newser.com
How CNS Pharmaceuticals Inc. stock benefits from global expansionJuly 2025 Update & Safe Entry Point Alerts - newser.com
Is CNS Pharmaceuticals Inc. forming a bottoming baseMarket Movers & Growth Focused Stock Pick Reports - newser.com
Sonnet BioTherapeutics (NASDAQ:SONN) and CNS Pharmaceuticals (NASDAQ:CNSP) Head-To-Head Comparison - Defense World
Measuring CNS Pharmaceuticals Inc.’s beta against major indicesBond Market & Weekly Chart Analysis and Trade Guides - newser.com
What analyst consensus says on CNS Pharmaceuticals Inc. stockIndex Update & High Conviction Buy Zone Alerts - newser.com
What MACD and RSI say about CNS Pharmaceuticals Inc.Quarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
What high frequency data says about CNS Pharmaceuticals Inc.Portfolio Return Report & Long-Term Growth Plans - newser.com
CNSP stock touches 52-week low at $0.09 amid sharp decline - MSN
Has CNS Pharmaceuticals Inc. found a price floor2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
What technical models suggest about CNS Pharmaceuticals Inc.’s comeback - newser.com
Using Bollinger Bands to evaluate CNS Pharmaceuticals Inc.2025 Technical Overview & Technical Pattern Alert System - newser.com
Published on: 2025-10-06 02:54:28 - newser.com
Published on: 2025-10-05 06:09:46 - newser.com
Will CNS Pharmaceuticals Inc. rebound enough to break evenInflation Watch & Expert Approved Trade Ideas - newser.com
Multi asset correlation models including CNS Pharmaceuticals Inc.Weekly Trend Recap & Long-Term Safe Investment Plans - newser.com
Custom strategy builders for tracking CNS Pharmaceuticals Inc.Weekly Market Summary & Expert Approved Momentum Ideas - newser.com
CNS Pharmaceuticals (NASDAQ:CNSP) Shares Down 3.3% – Time to Sell? - Defense World
Published on: 2025-10-01 05:57:30 - newser.com
What analysts say about CNS Pharmaceuticals Inc stockFederal Reserve Announcements & Explosive Capital Growth - earlytimes.in
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):